Effect of Microsatellite Status and Pan-Immune-Inflammation Score on Pathological Response in Patients with Clinical Stage III Stomach Cancer Treated with Perioperative Chemotherap...

por Gulmez, Ahmet, Coskun, Hatice, Koseci, Tolga, Ata, Serdar, Bozkurt, Berna, Cil, Timucin
Publicado 2023

Male Breast Cancer: Clinical, Demographical, and Pathological Features in a Cohort of 41 Patients

por Koseci, Tolga, Haksöyler, Veysel, Olgun, Polat, Koyuncu, Mahmut Bakır, Bozkurt Duman, Berna, Çil, Timuçin
Publicado 2021

Can LMWH improve the outcome of patients with inoperable stage III non-small cell lung cancer?

por Kucukoner, Mehmet, Isikdogan, Abdurrahman, Kaplan, Muhammed Ali, Inal, Ali, Zinciroglu, S., Cit, Murtaza, Cil, Timucin, Karadayi, Bilgehan, Dirier, Ahmet, Yildiz, Ismail
Publicado 2012

Proton pump inhibitors may reduce the efficacy of ribociclib and palbociclib in metastatic breast cancer patients based on an observational study

por Eser, Kadir, Önder, Arif Hakan, Sezer, Emel, Çil, Timuçin, İnal, Ali, Öztürk, Banu, Erçolak, Vehbi, Duman, Berna Bozkurt, Çelik, Halil, Köşeci, Tolga, Kesen, Oğuzhan
Publicado 2022